[Allergic bronchopulmonary aspergillosis]

Area of Science:

• Pulmonology
• Immunology
• Infectious Diseases

Background:

• Allergic bronchopulmonary aspergillosis (ABPA) is a complex immune response to Aspergillus fumigatus (Af) colonization in the bronchi.
• It primarily affects patients with asthma or cystic fibrosis, leading to severe lung damage like bronchiectasis and fibrosis.
• The exact reasons for developing hypersensitivity and ABPA remain unclear.

Purpose of the Study:

• To elucidate the pathogenesis of ABPA.
• To highlight the diagnostic challenges and current criteria for ABPA.
• To emphasize the established treatment protocols for ABPA.

Main Methods:

• Review of clinical, radiological, and immunological diagnostic criteria for ABPA.
• Analysis of the immunological response to Aspergillus fumigatus (Af) in affected patients.
• Evaluation of current treatment strategies, focusing on systemic steroids.

Main Results:

• ABPA involves recurrent bronchial obstruction, inflammation, and mucoid impaction.
• Diagnosis relies on a combination of clinical, radiological, and immunological findings.
• Systemic corticosteroids are the primary therapeutic intervention.

Conclusions:

• Understanding ABPA pathogenesis requires further research into hypersensitivity development.
• Accurate diagnosis necessitates a multidisciplinary approach.
• Effective management of ABPA hinges on prompt diagnosis and appropriate steroid therapy.